Slingshot members are tracking this event:
AbbVie's HUMIRA (adalimumab) Receives CHMP Positive Opinion to Treat Certain Forms of Non-Infectious Uveitis, a Disease that Can Severely Impact Vision
Slingshot Insights Explained
May 27, 2016
Don’t see a project related to the catalyst you care about?
Related Keywords Humira, Adalimumab, Chmp Positive Opinion, Non-infectious Uveitis, Visual Acuity, Corticosteroid